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Abstract
This study aims to determine the risk of recurrent stroke among patients at the
Indonesian national brain center (Rumah Sakit Pusat Otak Nasional, or RSPON)
who have suffered a first stroke. In this retrospective study, all the patients who
were selected had had their first stroke in 2014. The Kaplan-Meier and multivariate
Cox regression methods of data analysis were utilized. The results show that the
average survival period after stroke recurrence is 38 months, with the median being
25 months. Age, hypertension, obesity, and irregular control are the variables that
play a key role in the recurrence of strokes. Stroke patients who did not control
their conditions regularly after the first attack had an 8.7 times higher risk of stroke
recurrence. The incidence of recurrent stroke before 15 months was higher in those
who were overweight or obese (HR = 1.96 and 3.38), and those who had developed
pre-hypertension (HR = 2.26). Additionally, at observation after 15 months, levels of
grade 1 and 2 hypertension in the cohort were higher (HR = 2.86 and 2.07). To reduce
the risk of recurrent stroke, there is a need for stroke prevention via routine medical
examinations at clinics and community stroke seminars to raise awareness of the
risks. In addition, the establishment of a stroke community association in each region
is recommended.
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1. INTRODUCTION
Stroke is a health problem that needs special attention as it can attack anyone at any
time, regardless of race, gender or age. It isa brain disease that results from nerve-
function disorder, either locally or more generally, and is often sudden and progressive
[4]. Indonesia has the highest proportion of stroke sufferers in Asia and is also ranked
fourth in the world for stroke incidence (after India, China, and America). It was the
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most common cause of mortality in Indonesia in 2014, with 21% of deaths resulting
from the disease [6].
Patients can experience a number of complications after a first stroke, including
recurrent stroke, dementia, and depression. The risk of death increases after every
recurrent stroke. According to Supriyadi (2012), recurrent stroke patients are twice as
likely to die from a subsequent attack than those who suffer a first stroke due to heart
disease or high cholesterol. Prencipe (in Siswanto 2005) has found that the mortality
rate for a first stroke is 18–37%, but rises to 62% for recurrent strokes. The same study
suggests that 25% of those who recover from a first stroke will have another stroke
within 5 years.
“Rumah Sakit Pusat Otak Nasinal” (RSPON) is a specialist center that treats dis-
easesassociated with the brain and the nervous system. Its 2014 annual report shows
that stroke is the most common disease treated by the center (323 patients in 2014).
Moreover, 16% of these patients experienced another stroke during the same year.
This study aims to determine the factors that contribute to recurrent stroke at RSPON.
2. METHODS
This retrospective-cohort study used a survival-analysis technique that included mul-
tivariate Cox regression analysis. The data-collectionmethod involved observing the
participantsover a two-year period post-stroke and noting important events that
occurred. The secondary data was obtained from the patient’s medical registration
records at RSPON for 2014. The inclusion criteria were patients at RSPON who had
been diagnosed with stroke, who had complete medical records (including laboratory
results). Based on these criteria, 238 patients of 323 were selected for the study.
3. RESULTS AND DISCUSSION
Table 1 shows that 109 (45.8%) of the 238 patients suffered from stroke recurrence.
The number of male patients, 149 (62.6%), was higher than the number of female
patients. It was found that 44.3% of themales had another stroke during the follow-up
period, while 48% of females suffered from recurrence. In the < 60 years age group,
38% experienced stroke recurrence. For the ≥ 60 years age group, the recurrence
figure was higher, at 52.8%.
The percentage of patients who had heart disease was 28.6. We found that there
was no significant difference between patientswith heart disease and patientswithout
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heart disease, where stroke recurrencewas concerned. In addition, 46%of the patients
in the study were suffering from diabetes mellitus. Interestingly, stroke recurrence
occurred more frequently (52.29%) in the group of patients that did not have diabetes
mellitus than in the group that did (40.31% recurrence). The percentage of patients
having irregular control treatment was 56.3. Importantly, only 10.57% of patients hav-
ing regular control treatment experienced stroke recurrence, while 67.16% of patients
in the “irregular control” group experienced another stroke event. In the study pop-
ulation, hypercholesterolemia was found in 82.4% of the patients. Of these, 48.98%
suffered another stroke during the follow-up period. Of the remaining patients, who
had normal cholesterol levels, recurrent stroke was experienced in 30.95% of cases.
The percentage of patients with stage 2 hypertension (54.2%) was higher than the
percentages of patients with normal blood pressure (22.3%), with a pre-hypertension
classification (8.8%), or with stage 1 hypertension (14.7%). Of those with normal
blood pressure, 41.51% experienced stroke recurrence, while the figures for the pre-
hypertension, stage 1 hypertension, and stage 2 hypertension groups were 52.38%,
40%, and 48.06%, respectively.
The percentage of overweight patients was higher (49.2%) than the proportion of
patients with a normal BMI (42.9%) or the proportion of patients classified as obese
(8.0%). In the normal weight category, 45.09% of patients experienced another stroke
event, while the figures for the overweight group and the obese group were 47.86%
36.84%, respectively.
The contributory factors for recurrent stroke were found to be irregular control,
diabetes mellitus, age, hypertension and obesity. In addition, the effects of diabetes
mellitus, hypertension, obesity and age on the recurrence of stroke were dependent
on time.
Those in the “irregular control” category were found to be at greater risk of recur-
rent stroke. The probability of recurrent stroke in patients undergoing regular control
treatment was 11%, whereas the probability was 68% for those receiving irregular
treatment. This shows that levels of control make a difference to the likelihood of
subsequent stroke in patients who have suffered a first stroke. Indeed, patients who
do not undergo regular control procedures have an 8.71 times higher risk of recurrent
stroke.
This finding is in line with research conducted by Siswanto (2005), in which it was
found that the risk of recurrent stroke in patients receiving irregular treatment was
3.84 times higher than for patients undergoing regular control treatment. The results
suggest that a stroke patient who wants to control the condition and is willing to
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Table 1: Distribution figures for stroke patients at RSPON in 2014.
Variable Total Respondents Recurrent Stroke Event Survival Time (months)
n (%) n % Mean Median
Sex
Male 149 62.6 66 44.3 38.4 24.7
Female 89 37.4 43 48.3 37.5 25.2
Age
< 60 115 48.3 44 38.3 29.9 26.2
≥ 60 123 51.7 65 52.8 40.5 24.6
Stroke Type
Ischemic 124 52.1 58 46.8 38.1 25.0
Hemorrhagic 114 47.9 51 44.7 37.8 25.2
Heart Disease
Yes 68 28.6 78 45.9 39.6 24.7
No 170 71.4 31 45.6 33.4 25.3
Diabetes Mellitus
Yes 109 45.8 57 52.3 40.8 24.7
No 129 54.2 52 40.3 32.1 26.5
Irregular control
Yes 134 56.3 90 67.2 28.0 19.6
No 104 43.7 11 10.6 56.7 46.3
Duration of
hospitalization
< 7 day 90 37.8 44 48.8 36.3 23.9
7-14 day 101 42.4 43 42.6 35.6 26.2
≥ 15 day 47 19.7 22 46.8 44.5 26.5
Hypercholesterolemia
No 42 17.6 13 30.9 38.3 23.1
Yes 196 82.4 96 48.9 37.4 25.0
Hypertension
Normal 53 22.3 22 41.5 47.1 25.3
Pre-hypertension 21 8.8 11 52.4 26.9 23.9
Hypertension stage 1 35 14.7 14 40.0 38.2 24.3
Hypertension stage 2 129 54.2 62 48.1 37.9 26.5
Obesity
Normal 102 42.9 46 45.1 43.9 28.8
Overweight 117 49.2 56 47.9 32.7 24.6
Obese 19 8.0 7 36.8 37.7 25.0
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Table 2: Final Cox regression model for the factors associated with recurrent stroke.
Contributing variables 𝛽 Sig Exp(𝛽) 95%CI
Irregular Control 2.165 0.000 8.71 4.49-16.87
Diabetes Mellitus -0.050 0.873 0.95 0.51-1.76
Age 60+ yrs 0.031 0.058 1.03 0.99 -1.06
Hypertension (Ref. Normal)
Pre-hypertension 0.840 0.021 2.32 1.14 – 4.71
Hypertension stage 1 -1.168 0.69 0.31 0.88 – 1.09
Hypertension stage 2 -0.473 0.334 0.62 0.24 – 1.63
Obesity (Ref. Normal) 0.120
Overweight 0.746 0.367 2.11 0.42 – 10.66
Obese 1.288 0.110 3.62 0.75 – 17.58
take medication regularly will avoid recurrent stroke. Regular monitoring is designed
to facilitate early detection of increased risk of stroke recurrence, and enables anti-
recurrence treatment to commence immediately. Prompt diagnosis and early treat-
ment are essential for maximum recovery from stroke and for the prevention of recur-
rent stroke. Such an approach is consistent with the objectives of pharmacological
therapy for stroke, which are: (1) enabling open artery occlusion and the reperfusion
of ischemic brain tissue, (2) limiting the occurrence of occlusion thromboembolism, (3)
increasing the tolerance of cells (nerve cells are ischemic), (4) preventing dangerous
reperfusion, (4) preventing/treating complications and (5) preventing recurrent stroke.
The risk of recurrent stroke in patients who have diabetes mellitus is lower than for
those who do not have the condition. This result might be affected by the fact that
the Random Plasma Glucose test was not used to detect the disease in this study;
rather, GDNPP was taken as a marker of diabetes mellitus. Moreover, the question of
whether or not the diabetes was being controlled was not taken into account. There
are possibilities of bias, therefore, in this result. It is known that high blood sugar levels
in the pathology can increase the concentration of glycoprotein in the body, which is
a risk factor for vascular disease. In addition, changes to protasiklin production and to
plasminogen and blood-vessel activity can stimulate the thrombus. Diabetes mellitus
will accelerate small and large blood vessels throughout the body, including the brain,
which is one of the target organs of diabetes mellitus. As such, a high blood glucose
level will increase the likelihood of the spread of an infarcted area because lactic acid
forms as a result of the anaerobic metabolism of glucose, damaging brain tissue [13].
Time-dependent Cox regression showed that the covariate recurrent stroke risk was
affected by time and age. Stroke patients of ≥ 60 years were found to have a high risk
of recurrent stroke for 15months (HR 1.03). After 15months, however, the riskwas seen
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to reduce for this age group. Although a stroke can occur at any age, the risk increases
with age, due largely to the artheriosklerosis process and hypertension. These findings
differ slightly from those obtained by Supriyadi (2012), who found that patients aged
≥ 60 years had a 1.4 times higher risk of recurrent stroke than those aged <60 years.
Several studies have shown that recurrent strokes are more common in the elderly;
Hankey et al. (1998) found, for instance, that those aged 75–84 years at the time of
the first stroke have a 2.6 times higher risk of stroke recurrence.
Stroke patients who are overweight have a high risk of recurrent stroke (HR 1.96).
The risk of stroke recurrence for obese patients is also high (HR 3.38). Obesity triggers a
process connected with hypertension, hyperlipidemia, and diabetes mellitus. Research
conducted by Kurt et al. has shown that individuals with a Body Mass Index (BMI)
of <22 kg / m² and> 22 kg / m² are 1.84 times more likely to suffer from ischemic
stroke and 1.93 times more likely to experience hemorrhagic stroke (in Junaidi 2005).
Obesity is a condition in which the BMI is ≥ 30 kg/m², and is a predisposing factor for
cardiovascular disease and stroke. This is because the state of obesity is associated
with high blood pressure and high blood sugar levels. If someone is overweight, the
heart has to work harder to pump blood through the body, thus increasing blood
pressure. In addition, obesity can also accelerate the process of atherosclerosis in
adolescents and young adults. As such, weight loss can reduce the risk of stroke [8].
4. CONCLUSION
It can be concluded that age, hypertension, obesity, and irregular control influence the
recurrence of strokes. In this study, 45.8% of patients experienced recurrent stroke.
The average survival period after the occurrence of recurrent stroke was 38 months,
with the median survival period being 25 months. The patients who did not undergo
regular control treatment after the first attack were 8.7 times more likely to suffer
another stroke. The incidence of recurrent stroke before 15 months was higher for
those who were overweight and obese (HR = 1.96 and 3.38), and for those who had
developed pre-hypertension (HR = 2.26). Additionally, observations after 15 months
showed that levels of grade 1 and grade 2 hypertension had increased (HR = 2.86 and
2.07).
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5. RECOMMENDATIONS
The Ministry of Health, Jakarta Provincial Health Office, and RSPON need to develop
stroke-prevention programs in the community. Post-stroke health checks should also
be carried out routinely at clinics or Posbindu PTMs in each region. A program should
be developed to enable doctors to visit stroke patients, anda stroke community asso-
ciation should be put into place in each region. In addition, seminarsand education
sessions about strokesneed to be offered to local communities.
Finally, research into recurrent stroke must continue. In particular, additional risk
factors (such as smoking, diabetic mellitus control levels, the severity of the stroke,
the history of stroke within the family, levels of medication adherence, alternative
treatments, socioeconomic factors, and levels of family support) must be researched
in more detail to help prevent stroke incidence from increasing further.
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